Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis
Jessica C Garbern1, Jason Williams2, Amy C Kristl3
1Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, 7 Divinity Ave, Cambridge, MA 02138, United States of America; Department of Cardiology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States of America.
Insights
Interleukin-33 (IL-33) receptor ST2 signaling loss, not IL-33 levels, may drive periarteriolar fibrosis in aging and pressure overload. This pathway manipulation may not fully prevent or reverse cardiac fibrosis.
Area of Science:
- Cardiovascular biology
- Fibrosis research
- Molecular mechanisms of heart disease
Background:
- Diastolic dysfunction in heart failure with preserved ejection fraction is linked to cardiac microvascular dysfunction and periarteriolar fibrosis.
- Interleukin-33 (IL-33), acting through its receptor ST2, is known to prevent global myocardial fibrosis under pressure overload.
- The specific role of the IL-33/ST2 pathway in regulating periarteriolar fibrosis remains largely undetermined.
Purpose of the Study:
- To investigate the role of the IL-33/ST2 axis in modulating periarteriolar fibrosis.
- To examine age-related changes in IL-33 and ST2 expression and their correlation with periarteriolar fibrosis.
- To determine the impact of IL-33 or ST2 deficiency on periarteriolar fibrosis following pressure overload.
Main Methods:
- Comparative analysis of IL-33 and ST2 expression in young versus aged wild-type mice.
- Induction of pressure overload via transverse aortic constriction (TAC) in mice genetically deficient in IL-33 or ST2.
- Histological assessment of periarteriolar fibrosis in aged and TAC-subjected mice.
Main Results:
- Aging was associated with increased IL-33 expression, decreased ST2 expression, and enhanced periarteriolar fibrosis.
- Mice lacking ST2 exhibited significantly increased periarteriolar fibrosis after TAC compared to wild-type controls.
- Mice deficient in IL-33 did not show a significant increase in periarteriolar fibrosis post-TAC.
Conclusions:
- Loss of ST2 signaling, rather than altered IL-33 expression, appears to be a key factor in the development of periarteriolar fibrosis during aging and pressure overload.
- While the IL-33/ST2 pathway is implicated, targeting it alone may not be sufficient to prevent or reverse cardiac fibrosis.
Abstract:
Microvascular dysfunction in the heart and its association with periarteriolar fibrosis may contribute to the diastolic dysfunction seen in heart failure with preserved ejection fraction. Interleukin-33 (IL-33) prevents global myocardial fibrosis in a pressure overloaded left ventricle by acting via its receptor, ST2 (encoded by the gene, Il1rl1); however, whether this cytokine can also modulate periarteriolar fibrosis remains unclear. We utilized two approaches to explore the role of IL-33/ST2 in periarteriolar fibrosis. First, we studied young and old wild type mice to test the hypothesis that IL-33 and ST2 expression change with age. Second, we produced pressure overload in mice deficient in IL-33 or ST2 by transverse aortic constriction (TAC). With age, IL-33 expression increased and ST2 expression decreased. These alterations accompanied increased periarteriolar fibrosis in aged mice. Mice deficient in ST2 but not IL-33 had a significant increase in periarteriolar fibrosis following TAC compared to wild type mice. Thus, loss of ST2 signaling rather than changes in IL-33 expression may contribute to periarteriolar fibrosis during aging or pressure overload, but manipulating this pathway alone may not prevent or reverse fibrosis.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Endocrine Signaling
Bacterial Signaling
Yeast Signaling
What is Cell Signaling?


